Skip to main content
PI

Provigate, Inc

The startup develops a diagnostic instrument that utilizes perception-broadening sensors to accurately measure blood glucose levels in diabetic patients. This technology enables users to monitor their blood sugar regularly, facilitating better management of their lifestyle habits.

Tokyo, JapanFounded 20151050+ followers
Updated 3 months ago

Funding

$20.4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Product

Problem

Current methods for blood glucose monitoring, such as self-monitoring of blood glucose (SMBG) and continuous glucose monitoring (CGM), can be invasive, costly, and may not provide a complete picture of blood glucose variability for effective diabetes management. Reliance on HbA1c, while useful for long-term control, is not ideal for routine monitoring and behavior change due to its slow response to lifestyle adjustments.

Solution

Provigate is developing a remote blood glucose monitoring service that leverages glycated albumin (GA) levels to provide a more responsive and less invasive solution for managing diabetes and prediabetes. Their approach includes a mail-in testing method where patients can send blood or saliva samples weekly for GA analysis, as well as a point-of-care testing (POCT) method for at-home use. The results are delivered via a smartphone app, empowering users to monitor their average blood glucose levels over the past week and make informed lifestyle adjustments. By focusing on GA, which has a shorter half-life than HbA1c, Provigate aims to provide a more sensitive biomarker for behavior change and improved glycemic control.

Target Audience

Provigate's primary target audience includes individuals with diabetes or prediabetes, healthcare providers, and clinical researchers seeking a more convenient, less invasive, and responsive method for blood glucose monitoring and management.

Features

  • Weekly monitoring of glycated albumin (GA) levels through mail-in or at-home testing
  • Non-invasive saliva-based testing method in development
  • Point-of-care testing (POCT) device for rapid at-home analysis
  • Smartphone application for result delivery and behavior change support
  • High-performance liquid chromatography (HPLC) method for accurate GA measurement
  • Integration of AI-powered coaching app to induce behavior change
  • Telemonitoring by medical professionals
This profile is AI-generated and may contain inaccuracies.